Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cepheid, Conformis, Guide Sensmart, Oxford Immunotec, Surgical Innovation Associates.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accelerate Technologies, Aptorum Group, Billiontoone, Confirm Biosciences, Exagen, Genosity, Infirmary Health, Inflammatix, Karl Storz, Labcorp, LC-SCRUM-Asia, Jellagen, Mayo Clinic, Olink Proteomics, Premier, Proterixbio, Provider Network of America, Pulse Biosciences, Radiant Technologies, Saranas, Securiport, Seek Thermal, Stryker, Swift Biosciences, Wright Medical, Thermo Fisher Scientific, Well Health Technologies.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Immunovia, Irras, Istar Medical, Medasense, Moleculight.

Med-tech firms raising money in public or private financings, including: Acarix, Cardiac Dimensions, Caretrack Health, Coloplast, Francis Medical, Keepmed, Medtronic, Monarch Bioimplants, Owens & Minor.

New hires and promotions in the med-tech industry, including: Aziyo, Bioaffinity Technologies, Cyted, Deep Genomics, Exthera, Madaket, Omniome, Orb Health, Prometheus Biosciences, Solutionreach, Theralink Technologies.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Alexion, Apollomics, Ascendis, Brickell, Cardiol, Cipla, Daiichi Sankyo, Eagle, Eisai, FSD, Galapagos, Gilead Sciences, GW, Huya, Inovio, Kaken, Neurorx, Nicox, Ocumension, Olix, Rakuten Medical, Redhill, Remegen, Shionogi, Sinovac, Stemedica Cell Technologies, Symbio, Telix, Xiangxue Life Sciences.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Apeiron, Bridge, Cipla, Covaxx, Dr. Reddy’s, Durect, Eiger, Enterome, Immunic, Innovent, Johnson & Johnson, Novavax, Oncimmune, Pulmatrix, Sinovac, Takeda, Viralclear.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Beijing Biocytogen, Betta, Biohaven, Humanigen, Ilias Biologics, Immvira, Inventisbio, Opthea, Recce, Relief, Shanghai, Zai Lab.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Abbvie, Applied Biology, Astrazeneca, Bausch Health, Bharat Biotech, Clover, Codagenix, Daewoong, Dynavax, Eagle, Endo, Evolus, Fairjourney, Fundación Medina, Genetex, Geneva, Glaxosmithkline, Humanigen, Immunoprecise, Innoplexus, Iontas, Janone, Johnson & Johnson, Kanaph, Kazia, Kyan, Litevax, Lumen, Medicinova, Medytox, Minoryx, Moderna, Mymetics, Nascent, Neuren, Novavax, Oragenics, Par Sterile, Parexel, Pascal, Patrys, Pfizer, Precision Virologics, Samsung Biologics, Sanofi, Sosei Group, Sperogenix, Sumitomo Dainippon, Sun, Symbio, Taiho, Thermo Fisher Scientific, Trippbio, Vir.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acceleron, Aerie, Ascendis, BMS, Bridgebio, Histogen, Infinity, Medimetriks, Neuren, Organicell, Otsuka, Painreform, Pfizer, Seed Health, Windtree.